cyltezo
boehringer ingelheim international gmbh - adalimumab - hidradenitis suppurativa; arthritis, psoriatic; psoriasis; crohn disease; arthritis, juvenile rheumatoid; uveitis; arthritis, rheumatoid; colitis, ulcerative; spondylitis, ankylosing - imūnsupresanti - lūdzu, skatiet 4. sadaļu. produkta raksturojuma kopsavilkums 1 produkta informācijas dokumentā.
nebilet 5 mg tabletes
menarini international operations luxembourg s.a., luxembourg - nebivolols - tablete - 5 mg
zenadea 2 mg/0,03 mg apvalkotās tabletes
zentiva, k.s., czech republic - dienogestum, ethinylestradiolum - apvalkotā tablete - 2 mg/0,03 mg
climara 50 mikrogramu/24 stundās transdermāls plāksteris
bayer pharma ag, germany - estradiols - transdermālais plāksteris - 3,8 mg
logest 0.020 mg/0.075 mg apvalkotās tabletes
bayer pharma ag, germany - ethinylestradiolum, gestodenum - apvalkotās tabletes - 0.020 mg/0.075 mg
sanoral hct 40 mg/10 mg/25 mg apvalkotās tabletes
menarini international operations luxembourg s.a., luxembourg - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 40 mg/10 mg/25 mg
sanoral hct 40 mg/5 mg/25 mg apvalkotās tabletes
menarini international operations luxembourg s.a., luxembourg - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 40 mg/5 mg/25 mg
sanoral hct 40 mg/5 mg/12,5 mg apvalkotās tabletes
menarini international operations luxembourg s.a., luxembourg - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 40 mg/5 mg/12,5 mg
sanoral hct 40 mg/10 mg/12,5 mg apvalkotās tabletes
menarini international operations luxembourg s.a., luxembourg - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 40 mg/10 mg/12,5 mg
sanoral hct 20 mg/5 mg/12,5 mg apvalkotās tabletes
menarini international operations luxembourg s.a., luxembourg - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 20 mg/5 mg/12,5 mg